CAPSTAN THERAPEUTICS

HQ - San Diego

Summary

Capstan Therapeutics is a biotechnology company focused on developing in vivo cell reprogramming therapies using its proprietary CellSeeker tLNP platform.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 138 M

Avg. Deal Size£ 138 M

Market Context

Senior Management

Laura Shawver
President and CEO